Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials.
BACKGROUND:It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with th...
Main Authors: | Michael P Hengartner, Janus C Jakobsen, Anders Sørensen, Martin Plöderl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229381 |
Similar Items
-
Validation of the Montgomery-Åsberg depression rating scale in depressed patients in Serbia
by: Mihajlović Goran, et al.
Published: (2021-01-01) -
Montgomery-Asberg depression rating scale in clinical practice: Psychometric properties on Serbian patients
by: Vojvodić Petar, et al.
Published: (2020-01-01) -
Patients’ perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care
by: Carl Wikberg, et al.
Published: (2016-10-01) -
Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale
by: Ahmadpanah M, et al.
Published: (2016-03-01) -
The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder
by: Fantino Bruno, et al.
Published: (2009-05-01)